Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Cryopreserved Platelets vs Liquid Platelets in Bleeding Patients
NCT02078284Phase 1Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Nov 2014
- Primary completion
- Jul 2016
- Modality
- Tissue Cells
- Countries
- 1
01
Overview
Phase 1, randomised trial of cryopreserved platelets in Thrombocytopenia (8 cohorts), sponsored by U.S. Army Medical Research and Development Command. Primary endpoints: Adverse Events (AEs) by Level of Severity and Number of Subject With Thrombotic Events at Day 6. Started Nov 2014; status: completed.
02
Drugs
cryopreserved platelets
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT02078284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02078284.